McLean Asset Management Corp Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

McLean Asset Management Corp increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 2,142 shares of the healthcare conglomerate’s stock after acquiring an additional 65 shares during the quarter. McLean Asset Management Corp’s holdings in UnitedHealth Group were worth $1,083,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in UNH. Dark Forest Capital Management LP grew its holdings in UnitedHealth Group by 76.9% during the 2nd quarter. Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock valued at $374,000 after buying an additional 319 shares in the last quarter. Forefront Analytics LLC boosted its position in shares of UnitedHealth Group by 6.4% during the 2nd quarter. Forefront Analytics LLC now owns 877 shares of the healthcare conglomerate’s stock valued at $449,000 after acquiring an additional 53 shares during the last quarter. Buck Wealth Strategies LLC bought a new stake in shares of UnitedHealth Group during the 2nd quarter valued at about $7,112,000. Copperwynd Financial LLC boosted its position in shares of UnitedHealth Group by 24.2% during the 2nd quarter. Copperwynd Financial LLC now owns 1,775 shares of the healthcare conglomerate’s stock valued at $904,000 after acquiring an additional 346 shares during the last quarter. Finally, Magnolia Capital Advisors LLC boosted its position in shares of UnitedHealth Group by 322.7% during the 2nd quarter. Magnolia Capital Advisors LLC now owns 13,661 shares of the healthcare conglomerate’s stock valued at $6,957,000 after acquiring an additional 10,429 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 0.5 %

Shares of NYSE:UNH opened at $532.26 on Monday. The company has a market cap of $489.83 billion, a P/E ratio of 34.34, a PEG ratio of 1.41 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock’s fifty day moving average price is $541.04 and its 200-day moving average price is $564.79.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the business posted $5.83 earnings per share. The business’s quarterly revenue was up 6.8% on a year-over-year basis. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s payout ratio is presently 54.19%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the company. Royal Bank of Canada dropped their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research report on Wednesday, October 16th. Piper Sandler dropped their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. UBS Group decreased their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Finally, HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $627.74.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.